Immunoprecipitation is used for the analysis of target antigens in complex mixture of proteins. The protein of interest can be concentrated and purified in one step on an analytical scale via a specific antibody. Often, immunoprecipitated proteins are functionally active and can be further analyzed for enzymatic activity, interactions, modifications and structure.
The kit (Product No. 11719394001) contains all reagents necessary for cell lysis, solubilization, stabilization, and immunopurification of proteins.
1. Wash cells/tissue at least twice with ice-cold PBS to remove any remaining serum proteins from the culture medium. For one immunoprecipitation reaction a sample volume of 1 to 3 mL is recommended. Using a microcentrifuge, a volume of 1 mL is optimal.
2. Transfer sample to a Dounce homogenizer, pre-chilled on ice or any other type of micro-homogenizer. Be aware that the homogenization procedure might be critical for the functional integrity of the target antigen. Using a type B pestle, homogenize by repeated strokes (approx. 10).
3. Centrifuge homogenized suspension at 12,000 × g, 10 minutes, +2 to +8 °C in a table-top microfuge to remove debris. Alternatively, to prepare a high speed supernatant, centrifuge at 100,000 × g, 45 minutes, +2 to +8 °C.
4. Separate the supernatant and transfer to a microfuge tube (optimal volume 1 ml).
To reduce background caused by non-specific adsorption of irrelevant cellular proteins to Protein A Agarose, a preclearing step is recommended.
5. Add 50 μL of homogeneous Protein A Agarose suspension (25 μL bed volume) to 1 to 3 ml sample and incubate at +2 to +8 °C for at least three hours or overnight on a rocking platform.
6. Pellet beads by gravity sedimentation or centrifugation at 12,000 × g for 20 s in a microfuge. Transfer supernatants to fresh tubes.
7. Add an appropriate amount of the specific antibody and gently rock at +2 to +8 °C for one hour.
8. Add 50 μL of the homogeneous Protein A Agarose suspension to the mixture and incubate at +2 to +8 °C for at least three hours or overnight on a rocking platform.
9. Collect complexes by gravity sedimentation or centrifugation at 12,000 × g for 20 seconds in a microfuge.
10. Remove supernatant carefully, add 1 ml of wash buffer 1, resuspend the beads and incubate at +2 to +8 °C for 20 minutes on a rocking platform.
11. Repeat steps 9 and 10.
12. Collect complexes as described in step 9, remove supernatant, resuspend pellet in 1 ml of wash buffer 2, incubate at +2 to +8 °C for 20 minutes on a rocking platform, pellet the beads again and remove supernatant.
13. Repeat step 12.
14. Add 1 ml of wash buffer 3 to the pellet, resuspend, incubate at +2 to +8 °C for 20 minutes on a rocking platform, pellet the beads again and remove supernatant.
15. Remove the last traces of the final wash from the agarose pellet and from the walls and lid of the microfuge tube.
The immunoprecipitated proteins can be separated by any type of one- or two-dimensional electrophoresis system providing sufficient protein resolution. For a detailed protocol for SDS-polyacrylamide gel electrophoresis or two-dimensional electrophoresis, please refer to one of the standard textbooks or to manuals from manufacturers of electrophoresis equipment.
After electrophoresis, blot the gel onto a nitrocellulose or PVDF membrane using a standard Western blot protocol. To avoid damage or contamination of the membrane, always wear gloves when handling.
Sample preparation immunoprecipitation
Detection
Sample preparation and immunoprecipitation
Detection
Sample preparation and immunoprecipitation
Detection
Preclear the sample up to three times with Protein A Agarose before immunoprecipitation steps to remove all the proteins binding non-specifically to protein A/G . If the serum immunoglobulins cannot be entirely removed during Protein A Agarose preclearing, serum-free cell culture conditions before cell lysis are recommended. Alternatively, Protein A Agarose can be preloaded with the desired amount of specific antibody and the remaining protein A binding sites can be blocked with nonspecific control antibodies or serum.
To continue reading please sign in or create an account.
Don't Have An Account?